David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Building a sizable retirement nest egg requires a great deal of flexibility. When the economy is expanding, you need to dig deep for the best growth stocks. These are the names that can see their price-to-earnings (P/E) multiples expand to… Read More
It has been a crazy year for U.S. stocks, with the market surging higher into the spring, slumping badly in the summer and regaining some lost ground as the year came to a close. After all that swing, the S&P 500 stands right where… Read More
When Apple’s (Nasdaq: AAPL) engineers first dreamed up the concept of the iPad — perhaps the most important computer product in a decade — they had to rethink every aspect of its design. To make a very thin, lightweight, powerful device would have been hard to pull… Read More
It’s essential that a newly-public company remain in focus for investors. With enough attention, these new issues can climb steadily higher as the appearance of success draws more investors in. But if a company stumbles after an initial public offering (IPO), then it can… Read More
When a new drug backed by impressive clinical data hits the market, investors quickly size up its market potential. And when this drug receives a thumbs-up from Medicare and other insurance-reimbursement firms, projections of billion-dollar sales… Read More
Thanks to a big drop in sales in 2008 and early 2009, a wide number of companies were able to post impressive revenue gains in 2010 and 2011, as demand for goods and services returned to normal levels. But this might be the end of it: analysts expect sales growth… Read More
We’ve reached the time of year when investors flip the calendar and try to anticipate the events to come for 2012. I’ve weighed in with my own near-term strategies and provided a glimpse of my three favorite sectors for the coming year. Right now,… Read More
Executives at chip-equipment maker Lam Research (Nasdaq: LRCX) pulled off a masterstroke this week. A decision to buy Novellus Systems (Nasdaq: NVLS) has the makings of a “home run,” according to Citigroup. Why? Because the acquisition may boost Lam’s… Read More
Do analysts price targets matter? You bet. Any time you see a big gap between rational assessments of fair value and the current share price, it pays to dig deeper. Roughly 18 months ago, this is precisely why I saw value… Read More
I was talking with a colleague a few weeks ago and she wondered aloud whether the economic and political chaos in Italy — mainly the result of Europe’s ongoing sovereign debt crisis — was creating an opening for bargain-hunting investors. After all, we’re talking… Read More
